Trial intelligence / Profile preview

Tapentadol versus placebo for fibromyalgia with absent conditioned pain modulation

NL-OMON42796Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in fibromyalgia (FM) and Chronic widespread pain (CWP) comparing Tapentadol with Placebo (2 arms). Primary endpoints: Conditioned pain modulation and Pain relief. Started Mar 2016; status: active, not recruiting.

02

Drugs

tapentadol
03

Conditions

fibromyalgia (FM)Chronic widespread pain (CWP)

Beyond the preview

Go deeper on NL-OMON42796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call